AAAAAA

   
Results: 1-7 |
Results: 7
DIFFERENTIAL EFFECT OF UNFRACTIONATED HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN ON INTRAVASCULAR TISSUE FACTOR PATHWAY INHIBITOR - EVIDENCE FOR A DIFFERENCE IN ANTITHROMBOTIC ACTION
Authors: HANSEN JB SANDSET PM HUSEBY KR HUSEBY NE BENDZ B
Citation: Jb. Hansen et al., DIFFERENTIAL EFFECT OF UNFRACTIONATED HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN ON INTRAVASCULAR TISSUE FACTOR PATHWAY INHIBITOR - EVIDENCE FOR A DIFFERENCE IN ANTITHROMBOTIC ACTION, British Journal of Haematology, 101(4), 1998, pp. 638-646
DIFFERENTIAL EFFECT OF LOW-MOLECULAR-WEIGHT (LMWH) AND UNFRACTIONATED(UFH) HEPARIN ON INTRAVASCULAR TFPI - A PROPOSED MECHANISM FOR DIFFERENCE IN ANTITHROMBOTIC ACTION
Authors: HANSEN JB SANDSET PM HUSEBY KR HUSEBY NE OSTERGAARD P NORDOY A
Citation: Jb. Hansen et al., DIFFERENTIAL EFFECT OF LOW-MOLECULAR-WEIGHT (LMWH) AND UNFRACTIONATED(UFH) HEPARIN ON INTRAVASCULAR TFPI - A PROPOSED MECHANISM FOR DIFFERENCE IN ANTITHROMBOTIC ACTION, Thrombosis and haemostasis, 1997, pp. 29-29
TISSUE FACTOR PATHWAY INHIBITOR IN COMPLEX WITH LOW-DENSITY-LIPOPROTEIN ISOLATED FROM HUMAN PLASMA DOES NOT POSSESS ANTICOAGULANT FUNCTION IN TISSUE FACTOR-INDUCED COAGULATION IN-VITRO
Authors: HANSEN JB HUSEBY KR HUSEBY NE EZBAN M NORDOY A
Citation: Jb. Hansen et al., TISSUE FACTOR PATHWAY INHIBITOR IN COMPLEX WITH LOW-DENSITY-LIPOPROTEIN ISOLATED FROM HUMAN PLASMA DOES NOT POSSESS ANTICOAGULANT FUNCTION IN TISSUE FACTOR-INDUCED COAGULATION IN-VITRO, Thrombosis research, 85(5), 1997, pp. 413-425
DEPLETION OF INTRAVASCULAR POOLS OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) DURING REPEATED OR CONTINUOUS INTRAVENOUS-INFUSION OF HEPARIN INMAN
Authors: HANSEN JB SANDSET PM HUSEBY KR HUSEBY NE NORDOY A
Citation: Jb. Hansen et al., DEPLETION OF INTRAVASCULAR POOLS OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) DURING REPEATED OR CONTINUOUS INTRAVENOUS-INFUSION OF HEPARIN INMAN, Thrombosis and haemostasis, 76(5), 1996, pp. 703-709
EFFECT OF CHOLESTEROL-LOWERING ON INTRAVASCULAR POOLS OF TFPI AND ITSANTICOAGULANT POTENTIAL IN TYPE-II HYPERLIPOPROTEINEMIA
Authors: HANSEN JB HUSEBY KR HUSEBY NE SANDSET PM HANSSEN TA NORDOY A
Citation: Jb. Hansen et al., EFFECT OF CHOLESTEROL-LOWERING ON INTRAVASCULAR POOLS OF TFPI AND ITSANTICOAGULANT POTENTIAL IN TYPE-II HYPERLIPOPROTEINEMIA, Arteriosclerosis, thrombosis, and vascular biology, 15(7), 1995, pp. 879-885
INTRAVASCULAR DISTRIBUTION OF TFPI AND ITS ANTICOAGULANT POTENTIAL AFTER CHOLESTEROL-LOWERING IN TYPE-II HYPERLIPOPROTEINEMIA
Authors: HANSEN JB HUSEBY KR HUSEBY NE SANDSET PM NORDOY A
Citation: Jb. Hansen et al., INTRAVASCULAR DISTRIBUTION OF TFPI AND ITS ANTICOAGULANT POTENTIAL AFTER CHOLESTEROL-LOWERING IN TYPE-II HYPERLIPOPROTEINEMIA, Thrombosis and haemostasis, 73(6), 1995, pp. 943-943
THE ANTICOAGULANT POTENTIAL OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI)IS RESTRICTED TO ITS FREE-FORM IN HUMAN PLASMA
Authors: HUSEBY KR HANSEN JB HUSEBY NE NORDOY A
Citation: Kr. Huseby et al., THE ANTICOAGULANT POTENTIAL OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI)IS RESTRICTED TO ITS FREE-FORM IN HUMAN PLASMA, Thrombosis and haemostasis, 73(6), 1995, pp. 1260-1260
Risultati: 1-7 |